These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10999355)

  • 21. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Stealth adulterant on immunoassay testing for drugs of abuse.
    Cody JT; Valtier S
    J Anal Toxicol; 2001 Sep; 25(6):466-70. PubMed ID: 11550822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normalization of urinary drug concentrations with specific gravity and creatinine.
    Cone EJ; Caplan YH; Moser F; Robert T; Shelby MK; Black DL
    J Anal Toxicol; 2009; 33(1):1-7. PubMed ID: 19161663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beating the system: a study of a creatinine assay and its efficacy in authenticating human urine specimens.
    Villena VP
    J Anal Toxicol; 2010; 34(1):39-44. PubMed ID: 20109301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine adulterant test for oxidants yields positive results from microbial-contaminated urine.
    Brazwell E; Crossey M; Racz M; Quitoriano T; Chavez M
    J Anal Toxicol; 2004; 28(8):692-3. PubMed ID: 15586447
    [No Abstract]   [Full Text] [Related]  

  • 32. A new automated assay for the detection of synthetic urine in drug testing.
    Silva F; Kaileh I; Hobbs GA
    Drug Test Anal; 2019 Jul; 11(7):926-930. PubMed ID: 30920168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can synthetic urine replace authentic urine to "beat" workplace drug testing?
    Kim VJ; Okano CK; Osborne CR; Frank DM; Meana CT; Castaneto MS
    Drug Test Anal; 2019 Feb; 11(2):331-335. PubMed ID: 30194711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The defined HHS/DOT substituted urine criteria validated through a controlled hydration study.
    Edgell K; Caplan YH; Glass LR; Cook JD
    J Anal Toxicol; 2002 Oct; 26(7):419-23. PubMed ID: 12422995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of chromate adulteration of human urine by automated colorimetric and capillary ion electrophoretic analyses.
    Ferslew KE; Nicolaides AN; Robert TA
    J Anal Toxicol; 2003; 27(1):36-9. PubMed ID: 12587681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing.
    Dasgupta A; Wahed A; Wells A
    Am J Clin Pathol; 2002 Feb; 117(2):325-9. PubMed ID: 11863230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI).
    Paul BD; Jacobs A
    J Anal Toxicol; 2005 Oct; 29(7):658-63. PubMed ID: 16419396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A procedure for the detection of Stealth adulterant in urine samples.
    Valtier S; Cody JT
    Clin Lab Sci; 2002; 15(2):111-5. PubMed ID: 12776774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.